Publications (59) JOSE MARIA ECHAVE SUSTAETA publications

2024

  1. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 4, pp. 970-982

  2. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

    Vaccines, Vol. 12, Núm. 8

  3. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

    Respiratory Research, Vol. 24, Núm. 1

  2. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  3. Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment

    International journal of chronic obstructive pulmonary disease, Vol. 18, pp. 2887-2893

  4. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 12, pp. 1703-1715

  3. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

    Respiratory Medicine, Vol. 200

  4. Treatable traits in the NOVELTY study

    Respirology, Vol. 27, Núm. 11, pp. 929-940

  5. [Translated article] ANTES Program: One Year on

    Archivos de Bronconeumologia

2021

  1. Characterization of COPD admissions during the first COVID-19 outbreak

    International Journal of COPD, Vol. 16, pp. 1549-1554

  2. Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages

    Archivos de Bronconeumologia

2020

  1. Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

    Therapeutic Advances in Respiratory Disease, Vol. 14

2019

  1. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

    The Lancet Respiratory Medicine, Vol. 7, Núm. 9, pp. 771-779

2016

  1. Author’s reply

    International Journal of COPD

  2. The lung function profile of once-daily tiotropium and olodaterol via respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via a accuhaler® (Energito® study)

    International Journal of COPD, Vol. 11, pp. 193-205

2014

  1. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?

    International journal of chronic obstructive pulmonary disease, Vol. 9, pp. 1307-1314

  2. Non-Invasive Ventilation

    Clinical Intensive Care Medicine